News

Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of April 2022.

Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of March 2022.

Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of February 2022.

Prof. Aartsma-Rus’ personal highlights of the 2022 International Conference on Duchenne and Becker Muscular Dystrophy research updates.

Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of January 2022.

There are currently no approved stem cell therapies for DMD. You never pay for a clinical trial. Only trials on clinicaltrials.gov are legitimate.

Recent studies on Duchenne muscular dystrophy (DMD) have greatly deepened our understanding of the primary and secondary pathogenetic mechanisms. Guidelines…